| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.05B | -22.3% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 15.7% | Net margin -17.6% |
| Revenue Q/Q | +68.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 84.3% |
| R&D | ¥0.00B | 3.7% |
| SG&A | ¥0.02B | 37.4% |
| Tax & other | ¥-0.00B | -4.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
富满微 ・ 国科微 ・ 佩蒂股份 ・ 宇信科技 ・ 建科院 ・ 华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技 ・ 英搏尔 ・ 朗新科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies